These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 2231927

  • 1. Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.
    Hudson MA, Yuan JJ, Catalona WJ, Ratliff TL.
    J Urol; 1990 Dec; 144(6):1362-4. PubMed ID: 2231927
    [Abstract] [Full Text] [Related]

  • 2. Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
    Witjes JA, vd Meijden AP, Doesburg W, Debruyne FM.
    Eur Urol; 1993 Dec; 23(3):366-70. PubMed ID: 8508889
    [Abstract] [Full Text] [Related]

  • 3. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE, Marcus MD, Myers JA, Ratliff TL, Catalona WJ.
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The adverse effect of fibrin-clot inhibiting drugs on intravesical bacillus Calmette-Guérin efficacy for superficial bladder cancer.
    P'ng KB, Walsh MD, Seymour GJ, Lavin MF, Gardiner RA.
    Aust N Z J Surg; 1993 Feb; 63(2):127-30. PubMed ID: 8297300
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
    Haaff EO, Dresner SM, Ratliff TL, Catalona WJ.
    J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
    [Abstract] [Full Text] [Related]

  • 8. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors.
    Kavoussi LR, Torrence RJ, Gillen DP, Hudson MA, Haaff EO, Dresner SM, Ratliff TL, Catalona WJ.
    J Urol; 1988 May; 139(5):935-40. PubMed ID: 3361667
    [Abstract] [Full Text] [Related]

  • 9. Intravesical bacille Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder.
    Rogerson JW.
    Br J Urol; 1994 Jun; 73(6):655-8. PubMed ID: 8032833
    [Abstract] [Full Text] [Related]

  • 10. Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer.
    Lamm DL, DeHaven JI, Shriver J, Sarosdy MF.
    J Urol; 1991 Apr; 145(4):738-40. PubMed ID: 2005691
    [Abstract] [Full Text] [Related]

  • 11. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA, Jiménez León J, Martínez-Piñeiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [Abstract] [Full Text] [Related]

  • 12. The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin.
    deKernion JB, Huang MY, Lindner A, Smith RB, Kaufman JJ.
    J Urol; 1985 Apr; 133(4):598-601. PubMed ID: 3981707
    [Abstract] [Full Text] [Related]

  • 13. A randomized prospective comparison of oral versus intravesical and percutaneous bacillus Calmette-Guerin for superficial bladder cancer.
    Lamm DL, DeHaven JI, Shriver J, Crispen R, Grau D, Sarosdy MF.
    J Urol; 1990 Jul; 144(1):65-7. PubMed ID: 2193172
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer.
    Sarosdy MF, Lamm DL.
    J Urol; 1989 Sep; 142(3):719-22. PubMed ID: 2769847
    [Abstract] [Full Text] [Related]

  • 15. Bacillus Calmette-Guerin immunotherapy for bladder cancer.
    Lamm DL.
    J Urol; 1985 Jul; 134(1):40-7. PubMed ID: 3892050
    [Abstract] [Full Text] [Related]

  • 16. The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin.
    Bretton PR, Herr HW, Kimmel M, Whitmore WF, Laudone V, Oettgen HF, Fair WR.
    J Urol; 1990 Apr; 143(4):710-2; discussion 712-3. PubMed ID: 2313796
    [Abstract] [Full Text] [Related]

  • 17. [Progression and recurrence in the prostate and upper urinary tract following intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer].
    Wakabayashi Y, Okada Y, Mukumoto K, Hamaguchi A, Konishi T, Tomoyoshi T.
    Nihon Hinyokika Gakkai Zasshi; 1993 Dec; 84(12):2146-51. PubMed ID: 8309122
    [Abstract] [Full Text] [Related]

  • 18. Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin.
    Hillyard RW, Ladaga L, Schellhammer PF.
    J Urol; 1988 Feb; 139(2):290-3. PubMed ID: 3339727
    [Abstract] [Full Text] [Related]

  • 19. Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial.
    Hudson MA, Ratliff TL, Gillen DP, Haaff EO, Dresner SM, Catalona WJ.
    J Urol; 1987 Aug; 138(2):295-8. PubMed ID: 3298694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.